Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 25;325(20):2115-2116.
doi: 10.1001/jama.2021.5607.

S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021

Affiliations

S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021

Kevin A Brown et al. JAMA. .

Abstract

This study determined the spread of the B.1.1.7 SARs-CoV-2 variant in the Greater Toronto Area over 4 months by tracking S-gene target failure as marker.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. Percentage of Samples Positive for SARS-CoV-2 With S-Gene Target Failure
In the most recent week, March 25 to March 31, 2021, model-based estimates of S-gene target failure prevalence increased from 68.4% to 76.2% (7.8%; 95% CI, 7.3%-8.4%).
Figure 2.
Figure 2.. Daily Counts of SGTF (n = 4692) vs Non-SGTF Samples (n = 15 359)
In the most recent week, March 25 to March 31, 2021, model-based estimates of daily samples that tested of positive for S-gene target failure (SGTF) increased from 176 per day to 254 per day (weekly growth rate, 1.45; 95% CI, 1.18-1.75), whereas daily samples that tested positive for non-SGTF decreased from 81 per day to 79 per day (weekly growth rate, 0.97; 95% CI, 0.80-1.18). SGTF case counts increased in spite of a 6-week province-wide lockdown from December 26, 2020, to February 9, 2021.

References

    1. Kupferschmidt K. Danish scientists see tough times ahead as variant rises. Science. 2021;371(6529):549-550. doi:10.1126/science.371.6529.549 - DOI - PubMed
    1. Volz E, Mishra S, Chand M, et al. . Transmission of SARS-CoV-2 lineage B.1.1.7 in England: insights from linking epidemiological and genetic data. MedRxiv. Preprint posted on January 24, 2021. Accessed January 28, 2021. doi:10.1101/2020.12.30.20249034 - DOI
    1. Davies NG, Abbott S, Barnard RC, et al. ; CMMID COVID-19 Working Group; COVID-19 Genomics UK (COG-UK) Consortium . Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538):eabg3055. doi:10.1126/science.abg3055 - DOI - PMC - PubMed
    1. Ganyani T, Kremer C, Chen D, et al. . Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Euro Surveill. 2020;25(17). doi:10.2807/1560-7917.ES.2020.25.17.2000257 - DOI - PMC - PubMed
    1. Public Health Ontario . SARS-CoV-2 variants of concern results of point prevalence study. Published February 16, 2021. Accessed March 11, 2021. https://www.publichealthontario.ca/-/media/documents/ncov/voc/2021/02/sa...

Substances